Labviva AI Procurement Solutions Help Research Universities Navigate Rising Costs and Funding Cuts AI-native platform delivers operational efficiencies and millions in annual cost savings to...
— Chugai Venture Fund and the Gates Foundation join new wave of institutional backing for breakthrough BEYOND discovery platform — — BEYOND, an AI-driven drug...
Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch...
First procedures to be performed in the coming weeks at Alabama’s largest non-governmental healthcare system Purchase funded by the Thomas Foundation following FDA marketing authorization...
SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology for Cutaneous Melanoma (Version 1.2026), recognizing Merlin...
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU Prolacta Bioscience® today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100%...
As Interim President, Cherie Myatt will provide executive leadership across the organization, reinforcing Vaniam Group’s long-term commitment to value creation. Vaniam Group announced today that...
Improved Pro 2 performance and new SportsGuard workflow expand chairside 3D printing into pediatric and athletic preventive care SprintRay, the global leader in dental 3D...
Genomic Prediction, Inc., the frontrunner in advanced embryo screening, today announced the appointment of Santiago Munné, Ph.D., as Chief Scientific Officer. A globally recognized leader...
Hansa Biopharma AB, (“Hansa” or “the Company”), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase has been accepted by the...
In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration...
Lario Therapeutics (“Lario” or the “Company”), a biopharmaceutical company developing first-in-class precision medicines for epileptic and neurological disorders, today announced it has received a total...
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio...
Collaboration advances GD2 CAR-T investigational therapy for solid tumors toward clinical manufacturing and IND filing Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and...
$3 million investment strengthens foundation for the next generation of military family support Hope For The Warriors (HOPE) has received a $3,000,000 grant from Lilly Endowment...